Correlation Between Pfizer and Minnova Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Minnova Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Minnova Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Minnova Corp, you can compare the effects of market volatilities on Pfizer and Minnova Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Minnova Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Minnova Corp.

Diversification Opportunities for Pfizer and Minnova Corp

0.54
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Pfizer and Minnova is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Minnova Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Minnova Corp and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Minnova Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Minnova Corp has no effect on the direction of Pfizer i.e., Pfizer and Minnova Corp go up and down completely randomly.

Pair Corralation between Pfizer and Minnova Corp

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Minnova Corp. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 65.4 times less risky than Minnova Corp. The stock trades about -0.04 of its potential returns per unit of risk. The Minnova Corp is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  6.00  in Minnova Corp on September 1, 2024 and sell it today you would lose (5.74) from holding Minnova Corp or give up 95.67% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy99.21%
ValuesDaily Returns

Pfizer Inc  vs.  Minnova Corp

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Minnova Corp 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Minnova Corp are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile fundamental indicators, Minnova Corp reported solid returns over the last few months and may actually be approaching a breakup point.

Pfizer and Minnova Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Minnova Corp

The main advantage of trading using opposite Pfizer and Minnova Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Minnova Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Minnova Corp will offset losses from the drop in Minnova Corp's long position.
The idea behind Pfizer Inc and Minnova Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals